FFC
IHE icon

First Financial Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History

First Financial Corp’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-240
Closed -$12K – 419
2016
Q2 		$12K Buy
+240
New +$11.4K 0.01% 375

Other funds holding IHE

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

First Financial Corp's IHE Position: Q3 2016 in Review

First Financial Corp sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2016, closing a stake of 240 shares — an estimated $12K sold.

First Financial Corp first reported a position in IHE in Q2 2016 and held it in 1 quarter. The position peaked at $12K in Q2 2016. 85 funds tracked by Wall St. Rank hold IHE as of Q3 2016.

  • First Financial Corp reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
  • First Financial Corp sold 240 iShares US Pharmaceuticals ETF shares in Q3 2016, an estimated $12K.
  • First Financial Corp first reported a position in iShares US Pharmaceuticals ETF in Q2 2016 and held it in 1 quarter.
  • First Financial Corp's iShares US Pharmaceuticals ETF position peaked at $12K in Q2 2016.
  • 85 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2016.

Based on First Financial Corp's 13F filing for Q3 2016, filed 17 Oct 2016.